Atom | Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health (NIH)

Funding Amounts: Up to $350,000 direct costs per year | Project period up to 5 years

Summary: Supports secondary analysis and integration of existing datasets to elucidate cancer risk, prediction, survival, treatment response, and related outcomes.

Key Information: Clinical trials are not allowed; up to 10% of budget may be used for new data generation to validate key findings.

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing